Pentwater Capital Management LP Ngm Biopharmaceuticals Inc Transaction History

Pentwater Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$10.0 - $19.51 $100,000 - $195,100	-10,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$9.97 - $20.28 $90,727 - $184,548	-9,100 Reduced 47.64%	10,000 $185,000
Q3 2019 Nov 14, 2019	SELL	$13.09 - $18.19 $26,180 - $36,380	-2,000 Reduced 9.48%	19,100 $265,000
Q2 2019 Aug 14, 2019	BUY	$12.56 - $16.6 $265,016 - $350,260	21,100 New	21,100 $309,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.